The Catalyst Summit 2022 will be held from Friday, May 20th to Sunday, May 22nd, 2022, at Queen’s University, Kingston, Ontario. The event can also be attended online. In its third annual edition, Catalyst Summit 2022 is the premier Canadian conference dedicated to Psychedelic Medicine, and its growing role in the medical industry, society, and commerce. Political officers, city administrators, budding entrepreneurs, psychedelic researchers, medical & science specialists, legal experts, and health professionals are warmly invited to attend. The conference agenda will include keynote sessions, networking events, panel discussions, presentations, and in-depth discussions with over 80 renowned speakers, including seasoned researchers from world-class universities, industry leaders, senators, and medical experts in a variety of areas related to psychedelics.
The conference will explore a wide array of topics related to Psychedelic Medicine, drawing upon the latest science-backed data and evidence from clinical trials from around the world. Key themes include Standards, Ethics, and Best Practices; Legal and Regulatory Frameworks; The Business of Psychedelics; Pre-Screening and After-Medicine Integration; Safe, Legal Medicine Sourcing for Therapeutic Use; and Therapeutic Models and Protocols.
Distinguished speakers include Senator Larry Campbell; Kingston Deputy Mayor Gary Oosterhof; author of seven books and Invention Ambassador for the American Association for the Advancement of Science (“AAAS”), Paul Stamets; Dean of Health Sciences at Queen’s University and the CEO of the Southeastern Ontario Academic Medical Association (“SEAMO”), Jane Philpott, and clinical assistant professor of psychiatry at NYU, Anthony P. Bossis, Ph.D., among several others.
Attendees will also have the opportunity to network and foster relationships with industry peers at the After Party sponsored by the Psychedelic Association of Canada between 9 pm and 11 pm EST on Friday, May 20th.
The 3rd Annual Catalyst Summit is organized by Catalyst Presents Foundation, a premier organization well-recognized in the industry for events that enable networking opportunities, knowledge sharing, policy discussions, and lead generation with the objective of guiding Canada’s Psychedelic Journey.
The event will include an ‘In Conversation’ session with Health Canada representatives, moderated by David Clements, and a series of presentations with live Q&A sessions.
Dedicated sessions will examine psychedelic therapy, the role of the media vis-à-vis psychedelics, palliative care, ethics and consent, care for trauma, supply chain efficiencies, and business regulation.
The conference’s first session will be An Evening with Paul Stamets and special guests Dr. Jane Philpott, Larry Campbell, Kingston Deputy Mayor Gary Oosterhof, David Harder, and Natalie Harder from 7 – 9 pm on Friday, May 20th.
To learn more about the event, please visit https://catalystpresents.ca/
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.